Small molecule glucagon receptor antagonists: a patent review (2011 – 2014)
Author:
Publisher
Informa Healthcare
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543776.2015.1032250
Reference40 articles.
1. Global estimates of the prevalence of diabetes for 2010 and 2030
2. Something old, something new and something very old: drugs for treating type 2 diabetes
3. Management of type 2 diabetes: new and future developments in treatment
4. Glucagon and Glucagon-Like Peptide Receptors as Drug Targets
5. Hyperglycemia of Diabetic Rats Decreased by a Glucagon Receptor Antagonist
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Type 2 Diabetes Mellitus: Marketed Drugs and Mechanisms;Drug Discovery and Drug Development;2021
2. Small molecule glucagon receptor antagonists: an updated patent review (2015–2019);Expert Opinion on Therapeutic Patents;2020-06-18
3. Design, synthesis and structure activity relationships of indazole and indole derivatives as potent glucagon receptor antagonists;Bioorganic & Medicinal Chemistry Letters;2019-08
4. Current anti-diabetic agents and their molecular targets: A review;European Journal of Medicinal Chemistry;2018-05
5. A novel series of 4-methyl substituted pyrazole derivatives as potent glucagon receptor antagonists: Design, synthesis and evaluation of biological activities;Bioorganic & Medicinal Chemistry;2018-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3